This has led to delays, cancellations, or rationing of care in 1 in 3 health systems.

The FDA temporarily allowed overseas manufacturers to import some chemotherapy drugs to mitigate the shortage.

**Steroids and Hormonal Drugs**: Over 20% of hospital pharmacists reported shortages of steroids and hormonal drugs, impacting patient care.

The European Commission proposed measures like a voluntary solidarity mechanism and an early warning system to address these shortages.

The FDA worked with manufacturers to increase supply, although it cannot mandate production changes.

**Amoxicillin**: The FDA warned of a serious shortage of Amoxicillin, affecting treatment for common childhood infections.

**Pediatric OTC Medications**: High demand for pediatric over-the-counter medications like ibuprofen and Tylenol led to sporadic shortages, although manufacturers increased production to meet demand.

Healthcare systems have coped with these shortages through various strategies, such as:
- Importing drugs from overseas manufacturers.

- Offering therapeutic alternatives and rationing medicines.

- Encouraging joint procurement and medicine swaps within the EU.

- Increasing production and shipments of medications.

This has led to delays, cancellations, or rationing of care in 1 in 3 health systems.

Title:

Content: As drug shortage list grows, many hospitals face tough decisions on rationing care

More than half of hospital pharmacists are reporting a critical shortage of chemotherapy drugs and nearly all are reporting overall medicine supply gaps as prescription drug shortages near an all time high, according to a new survey.

Hospital pharmacists said drug shortages have forced 1 in 3 health systems to delay, cancel or ration care or switch to alternate drugs to continue to treat patients. And 99% are reporting some drug supply shortages, an American Society of Health-System Pharmacists survey of more than 1,000 pharmacists released Thursday found.

The organization reported shortages of 309 drugs, near the all-time high of 320 shortages in 2014. The scarcity of key drugs is prompting hospitals to find or substitute drugs and change treatment plans as needed.

“In some cases, there are no alternatives to the affected drugs, which puts patients at risk," ASHP Chief Executive Officer Paul W. Abramowitz said in a statement. "This issue requires quick action from Congress to address the underlying causes of shortages and ensure patients have the medications they need.”

Cancer drug shortages

In June, the Food and Drug Administration said it will temporarily allow overseas drug manufacturers to import some chemotherapy drugs.

The FDA allowed Qilu Pharmaceutical, a drug manufacturer in China, to import the injectable chemotherapy drug cisplatin in 50-milligram vials. Toronto pharmaceutical company Apotex Corp. will distribute the medication in the United States.

More than a dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin, used to treat lung, breast, prostate and gynecologic cancers. The National Cancer Institute said cisplatin and similar drugs are prescribed for 10% to 20% of all cancer patients.

In June, the National Comprehensive Cancer Network released a survey of 27 academic cancer centers that found 93% reported shortages of carboplatin and 70% faced shortages of cisplatin.

When cancer hospitals face such shortages, they attempt to make sure there's enough medication for patients to finish the course of treatment, said Mike Ganio, ASHP's senior director of pharmacy practice and quality.

Cancer hospitals facing such shortages might change medications for new patients starting on chemotherapy, said Ganio, a former pharmacy manager at an academic cancer center.

"You try to keep that patient on the same regimen as much as you can, unless they're failing it for some reason, and then you would switch," Ganio said.

Steroids, hormonal drugs also in short supply

More than 1 in 5 hospital pharmacists also reported shortages for steroids, hormonal drugs and oral liquids such as lidocaine, ibuprofen and amoxicillin.

A smaller number of pharmacists said heart medications, emergency prefilled syringes and drugs used for intensive care unit patients were in short supply. Others reported shortages of attention deficit hyperactivity disorder medicines, antimicrobial drugs and injectable opioids.

In all, about two-thirds of pharmacists said the shortages were "moderately impactful," which means they are managing shortages but patients are affected.

Pharmacists are managing the shortages by offering therapeutic alternatives, buying different vial sizes or concentrations and rationing medicines.

This article originally appeared on USA TODAY: Survey: Drug shortages are widespread, hospitals ration care

The FDA temporarily allowed overseas manufacturers to import some chemotherapy drugs to mitigate the shortage.

**Steroids and Hormonal Drugs**: Over 20% of hospital pharmacists reported shortages of steroids and hormonal drugs, impacting patient care.

The European Commission proposed measures like a voluntary solidarity mechanism and an early warning system to address these shortages.

Title:

Content: Brussels is planning for EU countries to share vital medicines and take emergency measures to avoid a repeat of shortages that hit the bloc a year ago.

The European Commission is proposing a “voluntary solidarity mechanism” requested by France and Germany and an early warning system flagging when drugs become scarce, according to draft proposals seen by the Financial Times. If insufficient donors come forward, EU capitals will be allowed to tap into an EU-funded stockpile set up during the Covid-19 pandemic and take other emergency measures.

In December and January western countries suffered a shortage of antibiotics including penicillin and amoxicillin, and painkillers such as paracetamol, especially in medicines used by children.

Among the emergency measures floated to prevent a repeat of that crisis, the commission could allow the extension of a drug’s shelf life, fast track approvals of alternative suppliers and support production increases.

Brussels will also encourage joint procurement of drugs from 2024 and medicine swaps with countries in the southern hemisphere, where peak winter demand happens at a different time.

The commission will draw up guidance for national stockpiles in 2024 and establish a Critical Medicines Alliance bringing governments, industry and civil society together. The commission declined to comment.

Three-quarters of countries reported a worsening of drug shortages in 2022, according to an industry survey. EU manufacturing is heavily reliant on imported active pharmaceutical ingredients from China and India.

Rising demand and disruption to supply chains have been compounded by inflation hitting the production of generic drugs, which typically sell at much lower prices than branded versions.

France has been actively encouraging the reshoring of basic medicine supply, with a giant paracetamol factory set to open in the country next year.

The EU is discussing whether to provide more funding for domestic production.

The commission’s proposal is scheduled to be approved on October 25 and could still change. Initially non-binding, it could lead to a Critical Medicines Act, with Brussels drawing up a list of vital medicines by year-end.

The commission also urges member states and the European parliament to approve its overhaul of pharmaceutical legislation, put forward in April. It includes plans to take control of drug production in the event of a public health emergency, a requirement for stockholders to inform Brussels of supply levels and for manufacturers to give early warnings of shortages.

An analysis by the European Medicines Agency and the commission found that unless there is unexpected demand the EU should avoid an antibiotics shortage this year.

“The information available today suggests that — if demand in the coming winter season does not differ significantly from the demand of recent years — the supply to the EU of key antibiotics seems to generally match demand,” the analysis said.

“However, this depends strongly on the compliance of industry with their legal obligations to ensure supply and their ability to adapt.”

Copyright The Financial Times Limited 2023. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this article

The FDA worked with manufacturers to increase supply, although it cannot mandate production changes.

Title:

Content: Clara Pitts has always strived for perfection.

The 17-year-old Utah native has been named a 2023 National Merit Scholarship finalist. And she heads to Brigham Young University as a freshman this fall.

But despite all of her achievements, Clara has one thing weighing on her mind: What if she fails?

Clara was diagnosed with attention-deficit/hyperactivity disorder (ADHD) in 10th grade, during the summer of 2020, after months of digital schooling had started to take its toll.

"For the first time, I started struggling with getting my homework done [and] having a set schedule that I had to do myself," Clara said. "It was because of online school."

So along with her mother, Rebekah, she made the decision to try medication.

"I didn't realize just how much my ADHD was inhibiting me from acting the same way as all of my friends until I had that experience of leveling the playing field," Clara said.

By December 2020, Clara was prescribed 10 milligrams of Adderall, a formulation of amphetamine mixed salts, to be taken twice a day. Immediately, she noticed a difference.

"It seemed like the logical course of action, like something that shouldn't have been happening in my brain was being fixed," Clara said. "Naturally, my brain goes really, really fast, and I don't even notice it because it's what I've grown up with, and it's the only mind I've ever experienced. But once I started having a different experience mentally, I felt a lot calmer."

For the two years that followed, Clara was finally able to lead what she called a normal life, managing school, extracurricular activities and social life -- all with the help of Adderall.

But in October 2022, Clara's sense of calm was stripped away when the US Food and Drug Administration announced a shortage of Adderall and its generic counterparts.

"I hadn't heard anything about a shortage," she said. "I didn't really take it seriously at first until later that week -- maybe three or four days later -- when I started to hear news about the shortage, and it really started to sink in."

CNN first spoke with Clara and her mother, Rebekah, about a month after the FDA's announcement. At the time, Clara had eight Adderall pills left in her prescription bottle -- enough to last her four days.

"Initially, I was just very surprised when I tried to refill the prescription and they would not [refill it]," Rebekah says. "Very quickly, I went from surprised to afraid."

On October 24, Rebekah texted Clara the bad news. The shortage had finally affected them, and their pharmacy could not refill Clara's medication due to the shortage.

"They wouldn't put you on a waiting list," Rebekah texted her daughter. "I'm just sitting here crying because I can't get you these meds."

Rebekah says she called eight local pharmacies, and each one turned up empty.

"I felt really emotional about it in that first week or two ... like I had failed my child, even though it wasn't my fault," Rebekah said. "I felt scared for what that would mean for her as a senior."

Why is there a shortage?

The FDA announced a shortage of Adderall on October 12. The agency noted that it was in communication with all manufacturers of amphetamine mixed salts and that one of those companies, Teva, was "experiencing ongoing intermittent manufacturing delays." Although other manufacturers continued to produce the drug, the agency said, "there is not sufficient supply to continue to meet U.S. market demand through those producers."

Jim McKinney, a spokesperson for the agency, told CNN that the manufacturing delay has been resolved and that the shortage is now "demand-driven."

Data from the analytics and research company IQVIA shows that the demand for Adderall has risen nearly 27% in recent years, with prescriptions jumping from 35.5 million in 2019 to 45 million last year.

On its website, the FDA lists eight manufacturers that have reported Adderall shortages to the agency. The website lists the shortage reason for some versions of the drug, such as "demand increase" or "shortage of active ingredient," but for other versions, it just says "other" or lists no reason at all.

Each year, the Drug Enforcement Administration tracks and sets a limit on production of amphetamine, one of the key ingredients in Adderall. It says that for the past three years, manufacturers didn't expend all of the ingredients that were available for their use.

"DEA is committed to ensuring that all Americans can readily access needed medications," an agency spokesperson told CNN in a statement. "We are aware that the pharmaceutical industry is claiming that there is a quota shortage for the active ingredients in ADHD drugs. Based on DEA's information -- which is provided by drug manufacturers -- this is not true."

CNN reached out to the eight manufacturers that reported shortages to the FDA.

Teva Pharmaceuticals, Epic Pharma and Rhodes Pharmaceuticals did not respond. Alvogen, SpecGX and Sunrise Pharmaceutical declined to comment.

Sandoz said it had enough product to meet current customer orders. Lannett also said it had enough to meet current customer orders but added that it did not have enough to fulfill increased demand.

McKinney, the FDA spokesperson, said supply is increasing.

"The FDA recognizes the potential impact that reduced availability of certain products may have on health care providers and patients and is working closely with numerous manufacturers and others in the supply chain to understand, mitigate and prevent or reduce the impact of intermittent or reduced availability of certain products," he said.

McKinney clarified that although the FDA is working with manufacturers, the agency does not make drugs and "cannot require a pharmaceutical company to make a drug, make more of a drug, or change the distribution of a drug."

Dr. Yoram Unguru, a pediatric hematologist and oncologist with joint faculty appointments at the Herman & Walter Samuelson Children's Hospital at Sinai and the Johns Hopkins Berman Institute of Bioethics, studies drug shortages.

He says a lack of transparency about details -- how big the shortage is and how much drug each company is making -- is hindering solutions.

"Pharmaceutical manufacturers are not required to disclose the reason for disrupted supply. Knowing the exact reason for a given shortage is always challenging," Unguru said. "It's really difficult to be able to anticipate and let alone come up with meaningful solutions if you don't know what the problem is."

The search for alternatives

Clara ultimately went without Adderall for two and half months as she coped with the stresses of senior year. She began taking a different ADHD medication, Vyvanse, in mid-January.

Rebekah says she hopes Adderall will be an option for Clara again one day, adding that she doesn't have the emotional stamina to keep searching for the medication.

"I would like her to have medication as an option and for it to be reliable, because college will probably be the hardest journey for her with ADHD."

Clara says that life without Adderall is like trying to see the world vividly while wearing smudged glasses.

"You go around with dirty glasses. You get used to it, and you don't realize that they're dirty. But when you clean them off, having that extra bit of clarity makes a world of difference."

The-CNN-Wire

™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.

CNN's Raenu Charles and Janelle Chavez contributed to this report.

0
0
0
0
0

Recommended for you

**Amoxicillin**: The FDA warned of a serious shortage of Amoxicillin, affecting treatment for common childhood infections.

Title:

Content:
The Shortages Are Coming

by Tyler Durden
Tuesday, Nov 08, 2022 - 09:20 PM

Authored by Michael Snyder via The End of The American Dream blog,

Do you remember in early 2020 when they told us that the shortages that we were experiencing would just be temporary?  Of course some of them were, but then more shortages just kept on erupting.  That wasn’t supposed to happen, and now it appears that our supply chain problems could potentially get a whole lot worse.  In just a few short months, we will be three years away from the beginning of the pandemic in the United States.  But instead of a “return to normal”, more shortages are on the way.  And in some cases, they could even be life threatening.

Let me give you an example.  We need Amoxicillin to treat some of the most common infections that our children experience.  Unfortunately, the FDA is warning us that we are now facing a very serious shortage of Amoxicillin…

Ear infections and strep throat.

Both are common childhood illnesses, for which the go-to prescription is in short supply, according to a recent nationwide alert from the U.S. Food and Drug Administration.

The warning specifically involves the powder, which pharmacists use to mix liquid Amoxicillin for childhood infections.

This is a really big deal.

According to one recent survey, close to two-thirds of all pharmacies in the nation are having difficulty getting Amoxicillin right now, and the national shortage of Adderall is even worse…

Nearly 66% of pharmacies are having challenges obtaining amoxicillin, according to a new National Community Pharmacists Association (NCPA) survey of 8000 pharmacy owners and managers, whereas 89% are realizing a shortage of Adderall.

Of course we are dealing with lots of other drug shortages at this moment as well.

In fact, according to the official FDA drug shortage list there are nationwide shortages of a whopping 183 different drugs in the United States right now.

We truly are in unprecedented territory.

Up in Canada, things are even worse.

If you can believe it, at this point the Canadians are facing “an acute shortage of basic painkillers”

The Canadian healthcare system is experiencing an acute shortage of basic painkillers, particularly acetaminophen and ibuprofen, which are commonly used to relieve pain and fever in children during flu season.

Canada’s Association of Medical Assistance in Dying Assessors and Providers (CAMAP) chose this perhaps awkward moment to roll out a webinar for healthcare professionals that advised them to offer assisted suicide to their suffering patients.

So why don’t the Canadians have enough Acetaminophen and Ibuprofen right now?

Well, we are being told that the primary reason is “a lack of raw ingredients to make the drugs”

CBC News quoted health officials who blamed “a lack of raw ingredients to make the drugs,” “an uptick in respiratory viruses fueled by the relaxed [Chinese coronavirus] measures,” and “panic buying” for the shortage of painkillers for children.

As I have covered in previous articles, most of the basic ingredients that go into our pharmaceutical drugs come from China.

So if you think that things are bad now, just wait until war with China erupts.

Once that happens, our pharmacies will get really empty and our entire healthcare system will experience a historic meltdown.

Switching gears, with Thanksgiving coming up I wanted to talk about the fact that we are now facing a nationwide shortage of turkeys

As CNBC reports, the price of turkey is up 73% from last year, a pretty astonishing figure. Experts attribute it to the bird flu, which has devastated turkey stocks this year. Apparently, the disease normally doesn’t flourish during the summer as farmers get their holiday flocks together. But, you know, the 2020s haven’t been easy so naturally, the flu hit hard right in the middle of the year when it could do the most damage.

The good news, if you want to call it that, is that you will still probably be able to get a turkey if you are willing to pay enough.

The bad news is that supplies of turkey just keep getting tighter and tighter.

One business owner in San Francisco recently stated that it is “like pulling teeth trying to get turkeys from the companies” at this stage…

But it’s not just the Thanksgiving bird that’s at risk — it’s your lunchtime turkey sandwich, too. San Francisco delis and butchers are already feeling the effects of the shortage.

“It’s like pulling teeth trying to get turkeys from the companies,” said Sal Qaqundah, owner of Arguello Market, a San Francisco cult favorite for its “world famous” turkey sandwich.

Unfortunately, we are also facing a shortage of butter in the weeks ahead.

The USDA is urging consumers not to “panic buy” butter so that there will be enough to go around for everyone…

Butter is another area where the war and cost of dairy products has affected supply, as the price of the condiment and baking ingredient has gone up a dollar per pound since January of this year, per Eater. Fearing a full-blown butter shortage, the USDA has asked consumers not to rush or panic buy, but simply secure what they need at a given time, per Best Life.

Did you ever imagine that we would be talking about a butter shortage in late 2022?

Things just keep getting crazier and crazier.

And if the diesel fuel shortages eventually get as bad as some are projecting, we could soon be facing severe shortages of countless products.

Our ships, our trains and our trucks run on diesel fuel.

So if there is not enough diesel fuel, we are going to have a real problem trying to fill up our stores with enough stuff for everybody.

Even now, supplies of diesel fuel are so tight that one big player in the industry just issued a major alert

A major fuel supply and logistics company is raising a red flag on upcoming diesel fuel shortages.

Mansfield Energy issued the alert Friday stating there was a developing diesel fuel shortage in the southeastern region of the United States. The company speculated that the shortage could be generated from “poor pipeline shipping economies” and a historically low supply of diesel reserves.

“Poor pipeline shipping economics and historically low diesel inventories are combining to cause shortages in various markets throughout the Southeast,” the company said. “These have been occurring sporadically, with areas like Tennessee seeing particularly acute challenges.”

There are a number of reasons why supplies of diesel fuel have gotten so tight.

But the biggest is the fact that imports from Russia have been totally cut off

But the primary reason is the cutoff of Russian imports. Prior to Russia’s invasion of Ukraine, the U.S. was importing nearly 700,000 barrels per day (BPD) of petroleum and petroleum products. Most of those imports were finished products and refinery inputs that boosted distillate supplies in the U.S.

The loss of those Russian imports have caused problems for refineries as they struggle to fill holes in their product slates. Refineries do have a small amount of flexibility in shifting gasoline production to diesel production. But it’s a relatively small amount (e.g., ~5% in a refinery I once worked in). That also means that if refiners do shift production, that also potentially creates shortages in the gasoline market.

So why don’t we just produce more ourselves?

Well, thanks to our politicians, the number of refineries in the United States has actually been declining in recent years even as our population has grown.

At this point we simply do not have enough refineries, and this is a problem that is not going away any time soon.

In the months ahead, we aren’t going to completely run out of diesel fuel as some people out there are suggesting.

But supplies may get so tight that it could potentially create widespread supply chain nightmares that are quite severe.

Let us hope that such a scenario does not materialize.

Because the American people are already angry enough about the economy.  In fact, a brand new survey has found that it is the number one issue for U.S. voters at this moment…

The Washington Post and ABC gave Americans eight top issues they will be considering when making their decision in a poll that showed likely voters split between the Democrats and Republicans.

The economy was cited by 26 percent of likely voters as one of the most important factors, followed by abortion with 22 percent and inflation and threats to democracy each by 21 percent.

For decades, we have been able to rely on our supply chains to continuously fill our stores with mountains of cheap goods.

But now our supply chains are breaking down.

In fact, our entire economic system is breaking down and most people are completely and utterly unprepared for the difficult times that are coming.

I know that many of you have been patiently waiting for a long time for life to “return to normal”.

Sadly, that isn’t going to happen.  The incredibly bad decisions that our leaders have been making are now catching up with us in a major way, and a great deal of pain is ahead.

*  *  *

It is finally here! Michael’s new book entitled “End Times” is now available in paperback and for the Kindle on Amazon.

0

**Pediatric OTC Medications**: High demand for pediatric over-the-counter medications like ibuprofen and Tylenol led to sporadic shortages, although manufacturers increased production to meet demand.

Title:

Content: Spokane, Washington  Est. May 19, 1883
19° Partly Cloudy
News >  Nation/World

Parents looking for children’s Tylenol, ibuprofen find empty shelves

Dec. 1, 2022 Updated Thu., Dec. 1, 2022 at 9:17 p.m.

By Jenna Portnoy, Daniel Gilbert, Ellie Silverman and Katie Shepherd Washington Post

People seeking over-the-counter medication for their sick children are often finding sparse or empty shelves, as a spike in respiratory illnesses pushes pediatricians and emergency rooms to the limit.

Usual supplies of fever- and pain-reducing medicines, such as liquid acetaminophen and ibuprofen recommended for children with RSV, flu or the coronavirus, have not kept up with demand in recent weeks in pockets of the country hit hardest by surging illnesses.

Unlike in Canada where the government has issued emergency orders to address a shortage of acetaminophen and ibuprofen, commonly known by the name brands Tylenol and Advil, and similar products, U.S. manufacturers and retailers emphasized that supplies should rebound within weeks. On the prescription side, increased demand for the antibiotic amoxicillin has caused shortages in the United States, Canada and parts of Europe.

In the meantime, pediatricians say they worry limited access to medicines could result in more urgent-care and emergency visits as parents struggle to keep sick children comfortable.

“It’s a huge problem,” said Kristina Powell, a pediatrician in Williamsburg, Virgina, and president of the Virginia chapter of the American Academy of Pediatrics. “This is a result of the ‘triple-demic.’ Parents run to Walmart or Target, the shelves are empty. … This is going to be a long fall and winter of viral infections.”

A crop of influenza-like illnesses, which includes RSV, hit the South and Southeast hard a month ago, federal data show, and those illnesses have slowly progressed westward. By mid-November, Texas, New Mexico and Tennessee reported the highest incidence of illness, while levels remained very high in Virginia and D.C., followed closely by Maryland, according to data tracked by the Centers for Disease Control and Prevention.

Kylie Moriarty, 30, of Buffalo, Misssouri, searched her local Walmart for Tylenol or ibuprofen to treat her sick 9-year-old daughter and found nothing but empty shelves. That seemed odd, she said, because just last week she had no trouble buying the same products for her 2-year-old son in a merry-go-round of illnesses affecting families with young children.

“I was very frustrated that it’s 2022 and we can’t keep something in stock for parents to help their children get better,” she said in a phone interview. “It makes me want to cry, almost, because these are my kids.”

She and her husband called other pharmacies looking for medicines to soothe the girl and couldn’t find any guaranteed availability.

“When they’re sick, there’s only so much that loving on them and cuddling with them you can do. So when there’s no medicine or something that you can give them … it’s hard,” Moriarty said.

Feeling powerless, the couple gave up and cautiously shared their younger child’s more concentrated medicine with the older one, which seemed to help. Just as they began to relax, their little boy came home from day care with a fever. Moriarty plans to schedule an appointment with his pediatrician for treatment – and samples to take home.

The ordeal reminded her of the height of the pandemic when supply chain problems left consumers scrambling for toilet paper and other basics.

Generic varieties play a large role in the market for over-the-counter comfort drugs, and that industry runs on profit margins so lean that companies typically lack capacity to boost production on short notice, according to supply chain experts. That left shelves bare during the early days of the pandemic.

The same dynamic is playing out now as RSV, flu and the coronavirus hit simultaneously, prompting sporadic shortages of commonly used ibuprofen and Tylenol at some hospitals and retail stores.

The extent of those shortages isn’t clear. The Food and Drug Administration hasn’t reported any shortages of fever or pain medications. Drugmakers, pharmacists and industry organizations say there aren’t any constraints to manufacturing and expect supplies to rebound within weeks.

The University of Utah’s Drug Information Service, which tracks drug shortages, received its first report of a shortage of liquid ibuprofen – generally for children – on Monday, and quickly confirmed it with several manufacturers. Most of the drugs tracked by the service are purchased in large quantities by hospitals, but some formulations had over-the-counter labels. Erin Fox, the service’s director, said it was impossible to know how widespread retail shortages were given the variety of store-branded versions.

“There are definitely distribution and supply chain problems that still exist,” she said, such as a company not being able to hire enough drivers. “These shortages seem to be mostly a demand spike and should resolve relatively quickly,” she added.

Until then, both chain stores and independent pharmacies are dealing with the unpredictability of high demand and uncertain supplies.

Martin McCarthy struck out at 5 p.m. Wednesday when he stopped by Brookville Pharmacy in Chevy Chase, Maryland, looking for liquid Motrin for his 10-year-old son, who probably picked up a bug at school.

The pharmacy’s stock of children’s fever reducers was depleted after two busy weeks of parents and grandparents stopping in to buy Tylenol or Motrin for little ones suffering from colds, RSV, flu and other viruses.

By Wednesday evening, only three boxes of generic ibuprofen chewables, two boxes of generic acetaminophen chewables and six boxes of suppository acetaminophen remained. Other parents peeked down the aisle looking for liquid fever reducer and fever reducer for children younger than 3, only to leave empty-handed.

McCarthy scanned the cold-medicine aisle for a few minutes and called home to confirm that his son would tolerate grape-flavored chewable tablets instead of the liquid Motrin he was used to.

“It is surprising because it’s basically completely out,” he said. “And it’s just generic.”

A spokeswoman for Walgreens said McCarthy’s experience is typical. Even if their usual choice of medication is unavailable because of high demand, parents can usually find an alternative.

“Although demand for pediatric OTC medications have increased, Walgreens is prepared and able to continue meeting the needs of our customers and patients. We are working with our diverse set of suppliers and distributors to ensure our patients have the products they need most,” Walgreen spokeswoman Zoe Krey said in a statement.

Martha Welman, a pediatrician and medical director at Neighborhood Health, a primary care provider serving low-income and underinsured patients in Alexandria, Arlington and Fairfax, said staff will sometimes call pharmacies to find medicines for patients – a time-consuming process at a busy time.

“If it’s between helping someone find a medicine or seeing a sick child, we have to make that choice. We’re all kind of compromising right now,” she said.

Perrigo, an Ireland-based manufacturer of over-the-counter products, said “shortages are occurring in a number of markets we supply” because of high demand. The company has increased production of medications for fever and pain by 46% through October compared with a year ago, and increased shipments by a similar rate.

The Consumer Healthcare Products Association, which represents companies making over-the-counter drugs, said parts of the country are seeing a rise in pediatric illnesses but that there aren’t “overall widespread shortages here in the United States” of children’s pain relievers.

“We understand it might be frustrating for some parents who are unable to quickly locate these products from their usual pharmacy or retailer due to limited out-of-stocks in some stores,” the association said in a statement, but it emphasized the importance of calling around for medications and not hoarding, which could lead to widespread shortages.

Elizabeth Murray, a pediatric emergency medicine physician at Golisano Children’s Hospital in Rochester, New York, said from the bed shortage to overflowing emergency rooms, the last thing parents need is another hurdle. But until the early and aggressive onset of respiratory illness abates, health care providers and parents have no choice but to ride it out together.

“Everyone would like to have one thing to blame and there isn’t one thing to blame,” she said. “This is happening for a variety of reasons and we’re going to move through it and we’re going to be OK.”

Local journalism is essential.

Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.

Subscribe now to get breaking news alerts in your email inbox

Get breaking news delivered to your inbox as it happens.

Healthcare systems have coped with these shortages through various strategies, such as:
- Importing drugs from overseas manufacturers.

- Offering therapeutic alternatives and rationing medicines.

- Encouraging joint procurement and medicine swaps within the EU.

- Increasing production and shipments of medications.


The Single-Aisle Aircraft Market is projected to grow from USD 86.6 billion in 2022 to USD 222.20 billion by 2030, at a CAGR of 12.5%.

This growth is fueled by the expansion of low-cost carriers, urbanization, and rising middle-class populations in emerging economies.

The Narrow-Body aircraft segment, favored for its versatility and cost-efficiency, is the largest and fastest-growing segment.

Regionally, North America leads in aerospace composites, but Asia-Pacific is poised to be the fastest-growing region, driven by increased commercial aircraft production in countries like China and India.

The aircraft leasing market, crucial for fleet expansion, is expected to exceed USD 453.2 billion by 2026, with Europe currently generating the highest revenue.

Key manufacturers like Textron are making strategic moves in sustainable aviation fuel (SAF) and electric aircraft, positioning themselves for long-term growth.

Textron's acquisition of Pipistrel and its focus on SAF highlight its commitment to sustainability.

The development of next-generation, fuel-efficient aircraft is a significant opportunity, with manufacturers investing in advanced materials and more efficient engines.

Digitalization and connectivity are also prominent trends, enhancing passenger experience and operational efficiency.

The Single-Aisle Aircraft Market is projected to grow from USD 86.6 billion in 2022 to USD 222.20 billion by 2030, at a CAGR of 12.5%.

Title:

Content: Friday, 08 September 2023 05:25 GMT

Global Single-Aisle Aircraft Market Is Projected To Reach The Value Of $222.20 Billion By 2030 X Herald

(MENAFN- Ameliorate Digital Consultancy) According to the latest report by Virtue Market Research, in 2022, the Global Single-Aisle Aircraft Market was valued at USD 86.6 billion and is projected to reach a market size of USD 222.20 billion by 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 12.5%.

Request Sample Brochure @

A prominent long-term driver for the Single-Aisle Aircraft market is the growing global demand for air travel. Even though the COVID-19 pandemic had a severe impact on the aviation industry, the long-term trend remains robust. The demand for single-aisle aircraft is fueled by several factors, including the expansion of low-cost carriers, increasing urbanization, and rising middle-class populations in emerging economies.

The COVID-19 pandemic had an unprecedented impact on the aviation sector, leading to grounded fleets, reduced passenger demand, and financial strain on airlines. This setback prompted airlines to rethink their fleet strategies, with some deferring aircraft orders and retiring older aircraft to cut costs. Additionally, the pandemic accelerated the adoption of safety and hygiene measures in aircraft cabins, leading to increased investments in cabin air filtration and touchless technologies.

A notable short-term driver for the Single-Aisle Aircraft market is the rebound in domestic and regional air travel. As countries reopen their borders and vaccination efforts progress, there is a growing preference for shorter flights, leading to increased demand for single-aisle aircraft. Airlines are reactivating grounded aircraft and placing orders for new, fuel-efficient models to meet this surge in regional travel.

An exciting opportunity in the Single-Aisle Aircraft market is the development of next-generation, fuel-efficient aircraft. With a growing emphasis on sustainability and reducing carbon emissions, aircraft manufacturers are investing in research and development to create more eco-friendly models. This includes the use of advanced materials, aerodynamic improvements, and more efficient engines. Airlines that invest in these next-gen aircraft can not only reduce their environmental footprint but also benefit from lower operating costs in the long run.

One of the prominent trends observed in the Single-Aisle Aircraft industry is the rise of digitalization and connectivity. In-flight Wi-Fi, entertainment systems, and integrated passenger services are becoming standard features in modern single-aisle aircraft. Airlines are leveraging these trends to enhance the passenger experience and gain a competitive edge. Additionally, digitalization plays a crucial role in aircraft maintenance and operations, helping airlines optimize their fleet performance and reduce downtime.

Customize The Report According to Your Needs @

Segmentation Analysis:

The global Single-Aisle Aircraft Market segmentation includes:

By Type of Aircraft: Narrow-Body, Wide-Body, Regional Aircraft

Among these, the Narrow-Body aircraft category stands out as the largest segment. These aircraft are designed for short to medium-haul flights and are favored by airlines for their versatility and cost-efficiency. Narrow-Body aircraft are well-suited for both domestic and international routes, making them the preferred choice for many carriers.

In terms of growth, the Narrow-Body segment takes the lead yet again. The market for Narrow-Body aircraft is witnessing significant expansion due to the increasing demand for regional and domestic travel. Airlines are looking to replace older aircraft with more fuel-efficient and environmentally friendly Narrow-Body models, driving the growth of this segment.

By Engine Type: Turbofan, Turboprop

Among these categories, Turboprop engines are the largest segment. These engines are commonly found in regional aircraft that operate shorter routes and require a different set of performance characteristics compared to their Turbofan counterparts. Turboprop engines are known for their fuel efficiency and reliability, making them a preferred choice for regional carriers.

However, when it comes to growth, Turbofan engines take the lead. The demand for Turbofan-powered Single-Aisle Aircraft is on the rise, driven by the need for higher efficiency, reduced emissions, and greater operational range. Airlines are increasingly opting for Turbofan engines in their narrow-body aircraft to meet the growing demand for longer-haul regional and international flights.

Purchase Full Report @

Regional Analysis:

The Single-Aisle Aircraft market spans across variregions, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. Each of these regions has its unique characteristics and influences on the market.

Asia-Pacific emerges as the largest region in this segment. This region encompasses numerfast-growing economies, a burgeoning middle class, and a robust travel and tourism industry. As a result, airlines in Asia-Pacific have been expanding their fleets to meet the increasing demand for air travel. With a foon domestic and regional routes, narrow-body aircraft have been particularly favored in this region, contributing to its leadership in the Single-Aisle Aircraft market.

In terms of growth, Europe takes the lead. Despite being a mature aviation market, Europe is experiencing a surge in demand for narrow-body aircraft, primarily due to the need for more fuel-efficient and environmentally friendly options. European airlines are increasingly looking to modernize their fleets with state-of-the-art single-aisle aircraft, thereby driving the growth of this segment in the region.

The Middle East & Africa region also shows promise in terms of growth, driven by the emergence of airlines in the Middle East as major global players. These airlines are expanding their networks and investing in modern, fuel-efficient narrow-body aircraft to meet the growing demand for long-haul travel.

North America, with its well-established aviation industry, continues to be a significant market for single-aisle aircraft. While it may not be the fastest-growing region, North America remains a stable and vital market for these aircraft, catering to both domestic and international routes.

South America, although a smaller market compared to the other regions, also contributes to the demand for single-aisle aircraft. Airlines in South America are focusing on modernizing their fleets to enhance operational efficiency and reduce emissions.

Latest Industry Developments:

  • One of the key strategies adopted by companies is a strong emphasis on fuel-efficient and environmentally friendly aircraft. With the aviation industry facing increasing pressure to reduce carbon emissions, manufacturers are investing in the development of next-generation single-aisle aircraft with improved fuel efficiency. This includes the use of advanced materials, aerodynamic design enhancements, and the incorporation of more fuel-efficient engines. Furthermore, there is a growing trend towards the electrification of aircraft systems, including electric taxiing systems and more electric aircraft architectures. These innovations aim to reduce the overall carbon footprint of single-aisle aircraft, aligning with global sustainability goals.
  • To enhance their market share, aircraft manufacturers are expanding their global reach and customer base. They are targeting emerging markets with fast-growing air travel demand, such as Asia-Pacific and the Middle East. These regions represent significant opportunities for fleet expansion, especially with narrow-body aircraft designed for short- to medium-haul routes. Another trend is fleet modernization. Airlines, particularly in mature markets like North America and Europe, are retiring older aircraft and replacing them with state-of-the-art single-aisle aircraft. This trend is driven by the need to improve operational efficiency, reduce maintenance costs, and enhance passenger comfort. Manufacturers that offer the latest technology and fuel-efficient options have a competitive advantage in this regard.
  • Connectivity and digital solutions are becoming increasingly important in the aviation industry. Airlines are seeking aircraft equipped with advanced connectivity options to enhance the passenger experience, provide in-flight entertainment, and enable seamless inteaccess. Manufacturers are responding by integrating cutting-edge connectivity solutions into their single-aisle aircraft offerings. Additionally, the use of data analytics and predictive maintenance has gained prominence. Airlines are leveraging data from their aircraft to optimize operations, reduce downtime, and lower maintenance costs. Aircraft manufacturers are incorporating these features into their products to meet the demand for data-driven solutions.

About Us:

Virtue Market Research stands at the forefront of strategic analysis, empowering businesses to navigate complex market landscapes with precision and confidence. Specializing in both syndicated and bespoke consulting services, we offer in-depth insights into the ever-evolving interplay between global demand and supply dynamics. Leveraging our expertise, businesses can identify emerging opportunities, discern critical trends, and make decisions that pave the way for future success.

Contact Us:

Virtue Market Research

Kumar Plaza, #103, SRPF Rd, Ramtekadi, Pune, Maharashtra 411013, India

E-mail:

Phone: +1-917 436 1025

MENAFN08092023004660010643ID1107033579

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

This growth is fueled by the expansion of low-cost carriers, urbanization, and rising middle-class populations in emerging economies.

The Narrow-Body aircraft segment, favored for its versatility and cost-efficiency, is the largest and fastest-growing segment.

Regionally, North America leads in aerospace composites, but Asia-Pacific is poised to be the fastest-growing region, driven by increased commercial aircraft production in countries like China and India.

Title:

Content:
Navigating The Skies Of Growth: Global Aerospace Composites Market Insights

(MENAFN- EIN Presswire)

Aerospace Composites Global Market Report 2024 : Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company's Aerospace Composites Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The 2024 Global Market Report on Aerospace Composites by The Business Research Company offers insights into market size, trends, and a global forecast spanning 2024-2033.” - The Business Research Company

LONDON, GREATER LONDON, UK, December 25, 2023 /EINPresswire / -- Year End Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies Reports And 25% Discount On Global Market Reports

Market Overview: Ascending from $26.25 Billion to $29.95 Billion in 2023
The global aerospace composites market experienced robust growth, advancing from $26.25 billion in 2022 to $29.95 billion in 2023, showcasing a remarkable Compound Annual Growth Rate (CAGR) of 14.1%. As the market evolves, it is poised for sustained expansion, projecting a market size of $51.83 billion by 2027, with a CAGR of 14.7%.

The global aerospace composites market is soaring to new heights, characterized by diverse fiber types, aircraft categories, manufacturing processes, resin varieties, and applications:
1 Fiber Type:
.Carbon Fiber Composites
.Ceramic Fiber Composites
.Glass Fiber Others
2 Aircraft Type:
.Commercial Aircraft
.Business & General Aviation
.Civil Helicopter
.Military Others
3 Manufacturing Process:
.AFP/ATL
.Lay-Up Process
.Resin Transfer Moulding Process
.Filament Winding Others
4 Resin Type:
.Benzoxazine
.Cyanate Ester
.Bismalimide
.Ceramic and Metal Matrix
.Thermosetting Others
5 Application:
.Interior
.Exterior

Explore the market with a detailed sample report:

Driving Force: Demand for High-Strength, Lightweight Materials The surge in demand for high-strength and lightweight composite materials is steering the aerospace composites market forward. The pursuit of energy efficiency and reduced fuel consumption is achieved through the use of lightweight materials, minimizing the aircraft's mass. This, in turn, leads to enhanced flight performance, structural strength, and stiffness, contributing to reduced carbon footprints. According to the '2020 State of the Industry Report' by Composites Manufacturing Magazine, the US composite end products market is anticipated to reach $33.4 billion by 2025, with glass fiber-based composites dominating the market.

Key Players Shaping the Horizon Major players shaping the aerospace composites market include Solvay, Toray Industries Inc., Mitsubishi Chemical Holdings, Hexcel Corporation, Teijin Limited, SGL Group, Spirit AeroSystems, Materion Corporation, Owens Corning, Spirit AeroSystems Inc., LEE Aerospace Inc., Gurit Holding AG, General Electric Corporation, Rolls-Royce Motor Cars Ltd., Kineco-Kaman Composites, and Nippon Graphite Fiber Corporation. These industry leaders contribute to market dynamics and foster innovation in composite material and process technologies.

Innovation Trends: Technological Advancements and Consortium Initiatives Companies in the aerospace composites market are steering their focus towards technological advancements to accelerate the development of next-generation aircraft and future mobility. Technologically advanced and modern aircraft, equipped with increased payload capacities and cost-efficiency, are replacing outdated models. For instance, GKN Aerospace, a UK-based company, launched the ASCEND consortium to advance lightweight structures, positioning the UK as a technology leader in future aerospace technologies. This initiative contributes to reducing carbon emissions and energy consumption in the aerospace industry.

Explore detailed insights into market trends, innovations, and growth opportunities with the complete report:

Regional Dynamics: North America Takes the Lead in 2022
In 2022, North America emerged as the largest region in the aerospace composites market. As the market evolves, Asia-Pacific is poised to be the fastest-growing region, offering significant opportunities for market players. The regions covered in the aerospace composites market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Aerospace Composites Global Market Report 2023 from TBRC covers the following information:
.Market size date for the forecast period: Historical and Future
.Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
.Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Aerospace Composites Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on aerospace composites market size, aerospace composites market drivers and trends, aerospace composites market major players, competitors' revenues, market positioning, and market growth across geographies. The aerospace composites market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Aerospace Fasteners Global Market Report 2023
report/aerospace-fasteners-global-market-report

Aerospace Robotics Global Market Report 2023
report/aerospace-robotics-global-market-report

Aerospace Materials Global Market Report 2023
report/aerospace-materials-global-market-report

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: ...

Check out our:
LinkedIn:
Twitter:
Facebook:
YouTube:
Blog:
Healthcare Blog:
Global Market Model: global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
...
Visit us on social media:
Facebook
Twitter
LinkedIn

Unveiling the Automotive Heads-Up Display Market: Growth Potential & Technological Advancements

MENAFN25122023003118003196ID1107655432

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Title:

Content: Global Aircraft Mounts Market to Reach Value of USD 1.13 Billion by 2030 | Skyquest Technology

Global aircraft mounts market is segmented on the basis of type, and application. Based on type, the market can be segmented into engine mounts, landing gear mounts, and APU mounts. Based on application, the market is segmented into commercial aircraft, military aircraft, and general aviation- Industry forecast 2023-2030

Westford, USA, Jan. 23, 2024 (GLOBE NEWSWIRE) -- According to SkyQuest report, the global aircraft mounts market is experiencing significant growth, primarily fueled by the surging demand for improved safety and comfort within airplanes. This rising emphasis on passenger well-being has led to the development and adoption of advanced mounting systems in aircraft. Moreover, the increasing production and repair activities in commercial aviation are expected to be pivotal in expanding the market.

Get sample copy of this report:

https://www.skyquestt.com/sample-request/aircraft-mounts-market

Browse in-depth TOC on the "Aircraft Mounts Market"

  • Pages - 157
  • Tables -  63
  • Figures – 75

The incorporation of cutting-edge machinery into specialty aircraft is poised to have a favorable influence on the global aircraft mounts market's expansion. The aviation industry in the United States, known for its robust infrastructure and expertise, is well-positioned to embrace these technological advancements. As the demand for commercial flights continues to surge domestically and internationally, the need for reliable and advanced mounting solutions in aircraft becomes increasingly pronounced.

 Report Scope & Segmentation:

AttributesDetails
Market Size in 2022USD 0.7 Billion
2030 Value ProjectionUSD 1.13 Billion
CAGR6.9%
Forecast Period2023-2030
Segments Covered
  • Type
  • Application
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Prominent Players in Global Aircraft Mounts Market

  • Lord Corporation
  • Hutchinson SA
  • Aircraft Spruce & Specialty Co.
  • Trelleborg AB
  • Tri-Mack Plastics Manufacturing Corporation
  • ITT Inc.
  • Precision Castparts Corp.
  • Unison Industries, LLC
  • LORD Corporation
  • Senior plc
  • Kaman Corporation
  • GKN Aerospace
  • PFW Aerospace GmbH
  • ITT Corporation
  • Aircraft Components Company
  • Sonex Aircraft, LLC
  • Koss Aerospace

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/aircraft-mounts-market

Commercial Aircraft Segment has Augmented Significantly due to Rising Demand for Mounts

Commercial aircraft segment stands as the dominant force in the global aircraft mounts market. This category encompasses a wide range of aircraft, including narrow-body, wide-body, and regional jets, all of which are instrumental in passenger transportation. The demand for mounts in commercial aircraft remains consistently high, given the ongoing expansion of the aviation industry.

North America has firmly established its dominance in the global aircraft mounts market in 2022. This position can be attributed to the region's thriving aviation industry, which is characterized by advanced infrastructure and a consistent demand for commercial flights. The United States, in particular, plays a leading role in the region, boasting a significant share in mount installations for commercial aircraft.

Military Aircraft Segment to Dominate Market due to Ongoing Modernization

Military aircraft segment is emerging as the fastest-growing sector within the global aircraft mounts market. This segment encompasses various aircraft, including fighter jets, transport planes, helicopters, and unmanned aerial vehicles (UAVs), all serving multiple critical defense applications. The rapid growth and dominance of military aircraft mounts can be attributed to defense forces' ongoing modernization and procurement initiatives worldwide.

Asia-Pacific is currently undergoing remarkable expansion within the global aircraft mounts market. APAC is marked by emerging economies such as China and India, which are experiencing substantial growth in their aviation sectors. This growth is notably driven by increased commercial aircraft production within these countries, buoyed by the surging demand for air travel and the tourism industry's expansion.

A comprehensive analysis of primary global aircraft mounts market players has been conducted recently. The report encompasses various aspects of the market, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavors to develop innovative solutions to cater to the growing demand.

Key Developments in Global Aircraft Mounts Market

  • In 2023, Spirit AeroSystems unveiled a significant collaboration with Joby Aviation, a leading electric Vertical Takeoff and Landing (eVTOL) aircraft manufacturer. The partnership aims to co-develop and provide composite structures, which encompass vital components like mounts, for Joby's electric air taxi aircraft. This alliance underscores the growing importance of advanced materials and technologies in the emerging eVTOL sector.
  • In 2023, Safran and Dassault Aviation embarked on a joint strategic partnership to pioneer and manufacture cutting-edge propulsion systems. This collaborative effort encompasses developing and producing a range of components, including mounts and related elements, designed specifically for future combat aircraft.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/aircraft-mounts-market

Key Questions Answered in the Global Aircraft Mounts Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.
  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market's future growth?

Related Reports in SkyQuest’s Library:

Global Military Simulation & Virtual Training Market

Global Aircraft Thrust Reverser Market

Global Military Battery Market

Global Aerospace and Defense Telemetry Market

Global Aerostat Systems Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

The aircraft leasing market, crucial for fleet expansion, is expected to exceed USD 453.2 billion by 2026, with Europe currently generating the highest revenue.

Title:

Content: Aircraft Leasing Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2032

The global aviation industry is experiencing unprecedented growth, fueled by increasing air travel rates and the demand for efficient aircraft. In tandem with this growth, the aircraft leasing market has emerged as a critical component of the aviation ecosystem, providing airlines with flexible leasing options to meet their fleet requirements. A recent report by Report Ocean forecasts that the aircraft leasing market size is poised to exceed USD 453.2 billion by 2026, with a robust growth rate of 6.8% during the forecast period.

Request To Download Free Sample of This Strategic Report @-https://reportocean.com/industry-verticals/sample-request?report_id=Pol8

Driving Factors Behind Market Growth

The surge in air travel rates is a primary driver propelling the demand for aircraft leasing. Airlines are opting for leasing arrangements to expand their fleets and meet the escalating demand for air travel. Aircraft leasing offers flexibility and cost-effectiveness compared to outright aircraft purchases, enabling airlines to optimize their fleet size based on fluctuating market conditions.

Aircraft leasing encompasses two primary lease types: dry lease and wet lease. In dry leasing, aircraft are leased without crew members, while wet leasing involves leasing aircraft along with trained crew, maintenance, and insurance. This flexibility allows airlines to tailor leasing agreements to their specific operational needs, further driving the adoption of aircraft leasing.

Additionally, factors such as the growth in global aviation industry, increasing regulations, demand for fuel-efficient commercial aircraft, attractive tax policies, and affordable lease rates contribute to the burgeoning aircraft leasing market. Emerging economies present significant growth opportunities for aircraft leasing, with technological advancements further enhancing the appeal of leasing options.

Regional Insights and Market Dynamics

Europe emerged as the highest revenue-generating region in the aircraft leasing industry in 2019, driven by high disposable income, advanced living standards, and the development of new aircraft. The region witnessed increasing adoption of aircraft leasing due to the operation of efficient commercial aircraft and technological advancements. However, North America is also a significant market for aircraft leasing, with well-established aviation infrastructure and a robust demand for air travel.

Get a Free Sample PDF copy of the report @-https://reportocean.com/industry-verticals/sample-request?report_id=Pol8

Asia-Pacific is poised to exhibit substantial growth in the aircraft leasing market, propelled by countries such as China, India, and Japan. Rising air traffic, economic development, and increasing demand for air travel in the region contribute to the growing adoption of aircraft leasing. Latin America, the Middle East, and Africa also present lucrative opportunities for market players, driven by factors such as infrastructure development and tourism growth.

Competitive Landscape and Key Players

The global aircraft leasing industry is characterized by the presence of both international and small to medium-sized vendors. Leading companies such as Aviation Capital Group, Boeing Capital Corporation, Air Lease Corporation, and International Lease Finance Corporation dominate the market. These companies continually innovate and collaborate with other industry players to meet the evolving needs of consumers and launch new products to stay competitive.

Segmentation and Market Outlook

The aircraft leasing market is segmented based on lease type, aircraft type, and region. Dry leasing and wet leasing represent the primary lease types, catering to the diverse needs of airlines. Aircraft types include wide-body aircraft and narrow-body aircraft, each serving specific operational requirements. Regionally, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa constitute the key market segments, offering insights into regional market dynamics and growth prospects.

Buy Now and Get a Discount of 30% @-https://reportocean.com/industry-verticals/sample-request?report_id=Pol8

Future Outlook and Conclusion

In conclusion, the global aircraft leasing market is poised for significant growth driven by increasing air travel rates, demand for fuel-efficient aircraft, and favorable market conditions. As airlines seek to optimize their fleets and enhance operational efficiency, aircraft leasing emerges as a strategic solution to meet evolving market demands. With technological advancements and infrastructure development, emerging economies present lucrative opportunities for market players. As the aviation industry continues to soar to new heights, aircraft leasing remains a vital component facilitating the expansion and modernization of airline fleets worldwide.

These responses will function a complete examination of the:

  • The markets’ present-day infrastructures
  • Market possibilities and challenges
  • Future plausible for increase in particular industries
  • Major geographic and market segments to target, and end-user goal organizations and their viable operational volumes
  • Representative and a price chain probability breakdown
  • Market dimension and boom price during the expected time frame.
  • The market’s important using forces
  • Key market traits are impeding market expansion.
  • Obstacles to market expansion.
  • Market’s pinnacle merchants.
  • Thorough SWOT analysis
  • Threats and possibilities confronted with the aid of the modern carriers in the world market.
  • Trending elements that affect the markets in the quite a number region.
  • Initiatives with a strategic center of attention on the pinnacle vendors.
  • PEST find out about of the five essential market regions.

Access Full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=Pol8

(*Note: The historical years and projected period in the report are flexible and can be tailored upon request. Additionally, the scope of the published report is adjustable to meet specific requirements, and customized analyses based on particular geographies or countries can be included as part of the customization.)

About Report Ocean:

Report Ocean is a renowned provider of market research reports, offering high-quality insights to clients in various industries. Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing their market share in today’s competitive environment. As a trusted source for innovative market research reports, Report Ocean serves as a comprehensive solution for individuals, organizations, and industries seeking valuable market intelligence.

Contact Information:

Email:sales@reportocean.com

Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, United States

Telephone: +1 888 212 3539 (US – Toll-Free)

For more information and to explore their offerings, visit their website at:https://www.reportocean.com/

Key manufacturers like Textron are making strategic moves in sustainable aviation fuel (SAF) and electric aircraft, positioning themselves for long-term growth.

Title:

Content: Textron: An Overlooked Aviation Value Opportunity

Textron has made huge strides with sustainable fuel and a valuable defense contract

16 hours ago
Summary
  • Textron's sustainability investments could pay off in the long run.
  • The company has also won a $70 billion Army contract, though this is under fire from a Lockheed Martin protest.

The aviation and defense industry can be difficult to assess due to its contract-based structure, geopolitical exposure and huge capital expenditures that may or may not pay off. As shown by cases such as the that of Boeing’s (

BA, Financial) 737 Max, a high-profile failure can lead to years of underperformance and financial losses for a company in this industry.

However, it is still possible to identify aviation and defense stocks with outperformance potential by looking for key tailwinds such as lucrative contracts, growing backlogs and technological advancements. One overlooked company that is doing well based on these criteria is Textron Inc. (

TXT, Financial).

From its humble beginnings as a synthetic yarn producer in 1923 (which was a cutting-edge product at the time), Textron’s predecessor company transitioned to a parachute maker in World War II and then began the process of making acquisitions to become an aviation, defense and industrial products conglomerate. Nowadays, it is home to several industry-leading brands, including Bell, Cessna, Beechcraft, E-Z-GO, Arctic Cat and more.

The company’s key areas of growth are aviation and defense, which are supported by a robust financial business. It recently marked a big defense milestone by winning a U.S. Army helicopter contract for its tilt-rotor aircraft, the V-280 Valor, to replace retiring Black Hawk aircraft, beating out Lockheed Martin (

LMT, Financial) and Boeing. The contract could be worth as much as $70 billion over the decades, according to the Army. Textron is also positioning itself as an early leader in sustainable aviation fuel (SAF), which could serve as a long-lasting growth booster as companies look to decarbonize.

Key contract set to drive sustainable revenue boost

A contract worth $70 billion over the next few decades may not be enough to move the needle at a giant like Lockheed Martin, but Textron has a market cap of just $14.09 billion as of this writing, and its revenue for full-year 2022 was $12.86 billion. Out of that, $3.1 billion in revenue came from the company’s Bell division, which houses its military rotorcraft and commercial helicopter operations. In other words, the V-280 Valor could be a significant revenue booster in the coming decades.

The contract has been protested by Lockheed Martin, which asked the U.S. Government Accountability Office to review the decision based on its assertion that Lockheed Martin’s proposal would provide better value to the Army and taxpayers. It should be noted this is just standard procedure and posturing; competitors cannot just take losing a contract at face value without protesting the decision because it would make them look weak and thus decrease their chances of getting more contracts in the future.

According to J.J. Gertler, a senior analyst at the Teal Group Corp., approximately 45% of such protests are successful, likely due to the highly speculative process of trying to figure out which contractor’s proposal is the best combination of value and performance. The results of this particular review are due on April 7, so the GAO’s final decision on the matter should go public soon.

However, a few years ago, Congress made it a requirement for the U.S. Department of Defense to explain to a company why it won or lost a competition, which has decreased the number of protests and increased transparency. “We are confident that the process we went through was disciplined and deliberate and it counted for the complexity of the decision that was involved,” Major General Robert Barrie said on the subject of the Army’s decision to award the contract to Textron.

Sustainable fuel investments could pay off in the long run

Textron’s Aviation division is even bigger than its Bell division, recording $5.1 billion in revenue in 2022. As the demand for aircraft of all types and sizes continues to grow on a global scale, companies are increasingly paying attention to the fuel consumption of their aircraft. Fuel is a significant cost of aircraft operation, and since there is a limited supply of fossil fuels in the world, it is destined to become increasingly expensive in the long run. Thus, aircraft manufacturers that make early moves in sustainable and alternative fuels and fuel efficiency can position themselves better for long-term growth.

All newer Textron Aviation turbine aircraft can operate with sustainable aviation fuel, which is made from renewable and waste feedstocks. While it is not clean-burning, SAF does reduce greenhouse gas emissions on a lifecycle basis. Buyers of certain Textron aircraft can get SAF in their initial tank upon delivery, and the company’s Wichita service center offers SAF refueling. Textron Aviation is aiming for all post-2020 growth to be carbon neutral, and it hopes to cut its carbon emissions in half by 2050.

Textron has also made a move into electric aircraft with its fourth-quarter 2022 acquisition of revolutionary Slovenian aircraft developer Pipistrel for $235 million. Pipistrel now makes up Textron’s new eAviation division. It’s far from being a profitability driver at the moment, as the business reported revenue of $6 million and a net loss of $10 million in the fourth quarter of 2022. However, Pipistrel is famous for having developed a light plane that can fly with an energy cost of as little as 1 euro ($1.10) per hour, and as Textron’s naming of the new division shows, it plans to focus primarily on developing the company’s electric aircraft.

Valuation and takeaway

Despite its promising growth outlook, Textron trades at a price-earnings ratio of just 17.25. Based on analyst estimates from Morningstar (

MORN, Financial), the forward price-earnings ratio is even lower at 13.43. This may be due in part to how choppy the company’s bottom line has been historically.

Textron maintains a solid balance sheet with a Piotroski F-Score of 7 out of 9 and an interest coverage ratio of 8.25, and its research and development spending typically runs around the mid 4% range of revenue, which does not break the bank. This strategy may draw criticism in a bull market, but in the current rising interest rate environment, it gives Textron a leg up to invest in growth.

The GF Value chart rates the stock as fairly valued. Despite the stock’s recent upwards trajectory and low price-earnings ratio, it has a volatile history, so the company may need to prove its ability to record significant growth before Mr. Market pays attention.

Disclosures

I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours. Click for the complete disclosure
Rating:
0 / 5 (0 votes)

What impact shall the carbon tax to be imposed by EU in 2026 have on aircraft market?

It is conducive to the sales of new aircraft with better fuel efficiency.

Textron's acquisition of Pipistrel and its focus on SAF highlight its commitment to sustainability.

The development of next-generation, fuel-efficient aircraft is a significant opportunity, with manufacturers investing in advanced materials and more efficient engines.

What impact shall the carbon tax to be imposed by EU in 2026 have on aircraft market?

It is conducive to the sales of new aircraft with better fuel efficiency.

What is Airbus doing to achieve sustainable aviation?

It is working on adopting innovative strategies.

It is making efforts to improve aircraft efficiency.

Digitalization and connectivity are also prominent trends, enhancing passenger experience and operational efficiency.

What is Airbus doing to achieve sustainable aviation?

It is working on adopting innovative strategies.

It is making efforts to improve aircraft efficiency.